Arthur Cox is very pleased to have partnered with Wachtell, Lipton, Rosen & Katz and Macfarlanes in advising Jazz Pharmaceuticals plc on its agreement to acquire GW Pharmaceuticals plc. On completion, the combined company will be a global biopharma leader with enhanced product diversification expected to provide accelerated double-digit revenue growth.

The Arthur Cox team was led by Michael Coyle (Corporate and M&A), Fintan Clancy (Tax) and Stephen Ranalow (Corporate and M&A) and included Kylie Dollard, Niamh O’Toole, Sinéad McDonagh and Andrew Hughes (Corporate and M&A) and Elaine Mooney and Dearbhla Ní Fhloinn (Tax).

Read more here.